Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”

Gehad Lotfy, Yasmine M. Abdel Aziz, Mohamed M. Said, El Sayed H. El Ashry, El Sayed H. El Tamany, Marwa M. Abu-Serie, Mohamed Teleb, Alexander Dömling, Assem Barakat*

*Corresponding author for this work

Research output: Contribution to journalErratum

Abstract

We have replaced the original Fig. 3 with a revised version, and we sincerely apologize for the inconvenience caused by our oversight. There was a mistaken duplication of the image of compound 5i against the MDA-MB 231 cells with the image for compound 5q against HepG-2 cells. Furthermore, the untreated control images were also changed with higher resolution ones. In the revised Fig. 3, we have corrected this error and provided the accurate representation.

Original languageEnglish
Article number107013
Number of pages2
JournalBioorganic Chemistry
Volume143
DOIs
Publication statusPublished - Feb-2024

Fingerprint

Dive into the research topics of 'Corrigendum to “Molecular hybridization design and synthesis of novel spirooxindole-based MDM2 inhibitors endowed with BCL2 signaling attenuation; a step towards the next generation p53 activators”'. Together they form a unique fingerprint.

Cite this